News

August 21, 2017August 21, 2017

National Ovarian Cancer Coalition Gears Up for Ovarian Cancer Awareness Month

News

The National Ovarian Cancer Coalition (NOCC) is launching a campaign with ovarian cancer survivors to raise awareness of the disease throughout September during National Ovarian Cancer Awareness Month. NOCC is preparing for a series ... Read more

August 19, 2017

Lynparza’s New Tablet Formulation Receives FDA Approval For Ovarian Cancer

News

A new formulation of Lynparza (olaparib) tablets received FDA approval to prevent disease progression and relapse in ovarian cancer patients. The new tablets allow patients previously taking the drug in capsule ... Read more

August 18, 2017August 18, 2017

Diet May Be Reason Pitavastatin, a Statin, Failed to Arrest Ovarian Cancer in Clinical Trials, Study Says

News

Pitavastatin, part of a class of statins widely used to lower blood cholesterol levels, was found to successfully target ovarian cancer cells and reduce tumor growth in mice, according to a ... Read more

August 16, 2017August 16, 2017

Trial of Vaccine to Prevent Ovarian Cancer Recurrence Expands to Advanced-stage Patients

News

TapImmune has amended the criteria for patient enrollment in a Phase 2 clinical trial testing its T-cell vaccine, TPIV 200, in women with ovarian cancer. While the study initially aimed to enroll 80 patients, it is ... Read more

August 14, 2017

BMS and Clovis Collaborate to Test Opdivo, Rubraca Combo Therapy in Ovarian, Other Cancer Types

News

A new clinical collaboration has been established between Bristol-Myers Squibb (BMS) and Clovis Oncology to evaluate the performance of Opdivo (nivolumab) in combination with Rubraca (rucaparib) in a Phase 3 trial for advanced ovarian cancer. ... Read more

August 2, 2017

UC San Diego Team Receives $5.8 Million to Develop Immunotherapy for Ovarian, Other Cancer Patients

News

Researchers at the University of California San Diego School of Medicine have received a $5.8 million state grant to develop an immunotherapy against hard-to-kill cancer stem cells. The team that won ... Read more

July 21, 2017

Parsortix-based Blood Test Out-performs CA125 in Detecting Ovarian Cancer, Studies Show

News

Studies in the United States and Europe successfully demonstrate the potential of a Parsortix-based blood test to out-perform current tests in diagnosing ovarian cancer, Angle has recently announced. More specifically, the ... Read more

July 19, 2017

Draft of New Guidelines Recommends No Ovarian Cancer Screening for Many Women Without Symptoms

News

Ovarian cancer screening in women of average age who have no symptoms offers no benefits and can cause harm, according to a draft of new screening guidelines. This means screening ... Read more

July 17, 2017July 17, 2017

Preventive Mastectomies Provide Little Survival Benefit for Ovarian Cancer Patients, Study Finds

News

Mastectomies and the removal of ovaries and fallopian tubes are considered preventive measures for women carrying BRCA genetic mutations linked to breast and ovarian cancer. But for women who have already had ... Read more

July 14, 2017July 14, 2017

Cancer Protein CA125 Blocks Investigational Therapy Farletuzumab’s Anti-Tumor Effectiveness, Study Finds

News

The protein CA125, which is commonly expressed on the surface of ovarian cancer cells and is secreted into the bloodstream, was found to block the activity of investigational drug farletuzumab. Farletuzumab ... Read more